Frontlight ResearchEarly access
Kidney cancer trials in France
48 of 57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Angers, Dijon, Le Mans, Marseille, Nice Cedex 2, Paris, Saint-Priest-en-Jarez, Toulouse Cedex 9, Villejuif
- Age
- 18 years and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - Phase 3Taking peopleA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Angers, Bayonne, Bordeaux Cedex, Creteil Cedex, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Limoges Cedex I, Montpellier, Nancy, Pierre-Bénite, Rouen, Suresnes
- Age
- 18 years and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00 - Phase 3Taking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Angers, Limoges Cedex I, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - Phase 3Taking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Angers, Bordeaux Cedex, Brest, Caen Cedex 5, Clermont Ferrand Cedex1, Lille, Marseille, Montpellier Cedex 5, Paris, Poitiers, Reims, Rennes Cedex, Saint-Herblain Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Villejuif
- Age
- 18 years and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - Phase 1/2Taking peopleSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Where
- Rennes Cedex, Strasbourg Cedex 2, Toulouse Cedex 9, Vandouvre Les Nancy, Villejuif
- Age
- 18 years to 120 years
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07049926 · EU 2024-516437-12-00 - Phase 1/2Not yet taking people in FranceA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Bordeaux Cedex, Lille, Villejuif
- Age
- 18 years and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - Phase 1Taking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Lyon, Paris, Toulouse Cedex 9
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - No phaseTaking peoplePost-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
- Where
- Marseille
- Age
- 18 years and over
- People
- 60
- Run by
- Institut Paoli-Calmettes
See details and how to joinNCT06882486 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Besancon Cedex, Bordeaux, Caen Cedex 5, Clermont Ferrand Cedex1, Marseille, Nice Cedex 2, Paris, Rennes Cedex, Saint-Herblain, Strasbourg Cedex 2, Vandoeuvre Les Nancy_ Cedex, Villejuif
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 1/2Taking peopleStudy of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Where
- Villejuif
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- Oncorena AB
See details and how to joinNCT05287945 - Phase 1Not yet taking people in FranceA Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Marseille, Villejuif
- Age
- 18 years and over
- People
- 112 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295 - Phase 3Taking peopleCARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- Where
- 71100, Ajaccio, Angers, Avignon, Bayonne, Besançon, Bordeaux Cedex, Boujan-sur-Libron, Boulogne-sur-Mer, Brest, Caen Cedex 5, Chalon Sur Saone Cedex, Chambéry, Clermont-Ferrand, Colmar Cedex, Compiègne, Creteil Cedex, Dax, Dijon, Epagny Metz-Tessy, Grenoble Cedex 9, La Roche Sur Yon Cedex 9, Lille, Limoges Cedex 1, Limoges Cedex I, Lyon, Marseille, Martinique, Mont-De-Marsan Cedex, Montpellier Cedex 5, Nice Cedex 2, Nimes Cedex 9, ORLEANS, Paris, Paris Cedex 20, Pau Cedex, Pierre-Bénite, Plérin, Poitiers, Reims, Rennes Cedex, Saint-Denis, Saint-Etienne, Saint-Mande, Saint-Priest-en-Jarez, St Herblain, St Nazaire, Strasbourg, Suresnes, Toulouse, Tours Cedex 9, Vandouvre Les Nancy, Villefranche-sur-Saône, Villejuif
- Age
- 18 years and over
- People
- 1,373 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-503317-29-00 - Phase 1Not yet taking people in FrancePhase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma
- Where
- Lyon
- Age
- 18 years and over
- People
- 26
- Run by
- Centre Leon Berard
See details and how to joinNCT07828249 · EU 2026-525526-38-00 - Phase 1/2Taking peopleKidney cancer
- Where
- Villejuif
- Age
- 18 years and over
- People
- 105 worldwide
- Run by
- Oncorena AB
See details and how to join2023-505605-16-00 - Phase 4Not yet taking people in FranceRandomized study evaluating the impact of an innovative and cooperative pathway integrating oncogeriatric, pharmaceutical and pharmacological follow-up in elderly patients (>70 years old) presenting with cancer and treated with oral therapy_POG
- Where
- Bron, Caluire-et-Cuire, Chevilly-Larue, Dijon, Lille Cedex, Lyon Cedex 04, Marseille, Paris, PARIS, Paris Cedex 20, Pierre-Bénite, Rennes Cedex, Saint-Cloud, Strasbourg Cedex 2, Toulouse, Villejuif
- Age
- 65 years and over
- People
- 794
- Run by
- Institut Gustave Roussy
See details and how to join2025-523610-83-00 - Phase 4Not yet taking people in FranceInnovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.
- Where
- Villejuif
- Age
- 70 years and over
- People
- 794
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07802847 - Phase 1/2Taking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Clermont Ferrand Cedex1, Dijon, La Tronche, Lyon, Marseille, Nantes, Pessac, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - Phase 1Taking peopleA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Bordeaux Cedex, Marseille, Villejuif
- Age
- 18 years and over
- People
- 281 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07195682 · EU 2025-522543-18-00 - Phase 1Taking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Bordeaux, Villejuif
- Age
- 18 years and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - Phase 4Taking peopleDigital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
- Where
- Avignon, Bayeux, Boulogne-sur-Mer, Caen, Caen Cedex 5, Coudekerque-Branche, Creil, Dijon, Epagny Metz-tessy, Lorient, Lyon, Montpellier Cedex 5, Mulhouse, Nice Cedex 2, Poitiers, St Etienne Cedex 2, Suresnes, Tours, Vannes
- Age
- 18 years and over
- People
- 83
- Run by
- Centre Francois Baclesse
See details and how to joinNCT07028125 · EU 2024-518991-30-00 - No phaseTaking peopleResearch of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
- Where
- Toulouse
- Age
- 18 years and over
- People
- 450
- Run by
- Institut Claudius Regaud
See details and how to joinNCT06967961 - Phase 1Taking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Marseille, Nice, Suresnes, Toulouse
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - Phase 2Taking peopleRadiopharmaceutical Treatment of Advanced Kidney Cancer
- Where
- Caen Cedex 5, Creteil, Villejuif
- Age
- 18 years to 100 years
- People
- 48 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06783348 · EU 2024-517899-38-00 - Phase 1/2Not yet taking people in FranceA First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Where
- Lille, Paris, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00 - No phaseTaking peopleRein 3D PRINT MECHANICS
- Where
- Bordeaux
- Age
- 18 years and over
- People
- 50
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT06525831